In Patient Services
- Last Updated On :
Inpatient Services
A facility for indoor admission of patients undergoing Radionuclide Therapy is available in ward D1. The department has been providing radionuclide therapy to patients with hyperthyroidism and thyroid cancer with 131-I. There is a specifically designed isolation ward/beds for thyroid cancer patients duly approved by BARC/AERB. Other radionuclide therapies include bone pain palliation, Radiation synovectomy, PRRT, PSMA therapy, FAPi therapy, treatment of inoperable hepatocellular carcinoma (HCC) with 188Re-lipiodol, etc. The department is also one of the pioneers in the field of targeted ALPHA- therapy.
